
TY  - JOUR
TI  - ASBMR 2010 Annual Meeting FR0005–FR0485
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650251302
DO  - doi:10.1002/jbmr.5650251302
SP  - S82
EP  - S135
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_2
DO  - doi:10.1111/jgh.12363_2
SP  - 23
EP  - 693
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Internal Medicine Journal
JA  - Intern Med J
VL  - 46
IS  - S2
SN  - 1444-0903
UR  - https://doi.org/10.1111/imj.13052
DO  - doi:10.1111/imj.13052
SP  - 5
EP  - 50
PY  - 2016
ER  - 

TY  - JOUR
TI  - European Society of Veterinary Clinical Pathology (ESVCP) 8th Annual Congress
JO  - Veterinary Clinical Pathology
VL  - 35
IS  - 4
SN  - 0275-6382
UR  - https://doi.org/10.1111/j.1939-165X.2006.tb00169.x
DO  - doi:10.1111/j.1939-165X.2006.tb00169.x
SP  - 474
EP  - 488
PY  - 2006
ER  - 

TY  - JOUR
TI  - 2017 ACCP Annual Meeting
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 37
IS  - 12
SN  - 0277-0008
UR  - https://doi.org/10.1002/phar.2052
DO  - doi:10.1002/phar.2052
SP  - e124
EP  - e238
PY  - 2017
ER  - 

TY  - JOUR
TI  - Concurrent Abstracts Session Four: Wednesday 25th May 0900‖1030
JO  - Journal of Paediatrics and Child Health
JA  - Journal of Paediatrics and Child Health
VL  - 52
IS  - S2
SN  - 1034-4810
UR  - https://doi.org/10.1111/jpc.13194_3
DO  - doi:10.1111/jpc.13194_3
SP  - 78
EP  - 104
PY  - 2016
ER  - 

TY  - JOUR
TI  - Short papers
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 102
IS  - S7
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.9940
DO  - doi:10.1002/bjs.9940
SP  - 9
EP  - 87
PY  - 2015
ER  - 

TY  - JOUR
TI  - 4th Congress of the International Pediatric Transplant Association Abstracts
JO  - Pediatric Transplantation
VL  - 11
IS  - s1
SN  - 1397-3142
UR  - https://doi.org/10.1111/j.1399-3046.2007.00684.x
DO  - doi:10.1111/j.1399-3046.2007.00684.x
SP  - 35
EP  - 114
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Journal of Paediatrics and Child Health
VL  - 48
IS  - s1
SN  - 1034-4810
UR  - https://doi.org/10.1111/j.1440-1754.2012.02411.x
DO  - doi:10.1111/j.1440-1754.2012.02411.x
SP  - 8
EP  - 81
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts of the 8th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Paris, France, 4-6 December 2015
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - Journal of Cachexia, Sarcopenia and Muscle
VL  - 6
IS  - 4
SN  - 2190-5991
UR  - https://doi.org/10.1002/jcsm.12087
DO  - doi:10.1002/jcsm.12087
SP  - 398
EP  - 509
PY  - 2015
ER  - 

TY  - JOUR
TI  - Scientific Exhibits
JO  - Journal of Medical Radiation Sciences
JA  - J Med Radiat Sci
VL  - 61
IS  - S1
SN  - 2051-3895
UR  - https://doi.org/10.1002/jmrs.74
DO  - doi:10.1002/jmrs.74
SP  - 184
EP  - 343
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Haemophilia
VL  - 18
IS  - s3
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2012.02820.x
DO  - doi:10.1111/j.1365-2516.2012.02820.x
SP  - 1
EP  - 208
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 23
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2009.00689.x
DO  - doi:10.1111/j.1472-8206.2009.00689.x
SP  - 1
EP  - 112
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 25
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2011.00930.x
DO  - doi:10.1111/j.1472-8206.2011.00930.x
SP  - 1
EP  - 111
PY  - 2011
ER  - 

TY  - JOUR
TI  - 141st Annual Meeting of the American Neurological Association
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 80
IS  - s20
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.24759
DO  - doi:10.1002/ana.24759
SP  - S1
EP  - S265
PY  - 2016
ER  - 

TY  - JOUR
AU  - Arana, A.
AU  - Morton, N. S.
AU  - Hansen, T. G.
TI  - Treatment with paracetamol in infants
JO  - Acta Anaesthesiologica Scandinavica
VL  - 45
IS  - 1
SN  - 0001-5172
UR  - https://doi.org/10.1034/j.1399-6576.2001.450104.x
DO  - doi:10.1034/j.1399-6576.2001.450104.x
SP  - 20
EP  - 29
KW  - Analgesic: non-opioid
KW  - paracetamol
KW  - pharmacology
KW  - pharmacokinetics
KW  - infants
PY  - 2001
AB  - Background: Paracetamol (N-acetyl-p-amino-phenol) or acetaminophen has become the most widely used analgesic and antipyretic in children. However, there is a wide discrepancy between the extent to which paracetamol is used and the limited available pharmacological data in small infants. The purpose of this article is to present a review of the current literature regarding the use of paracetamol in neonates and infants with a particular emphasis on pharmacological issues. Methods: A MEDLINE search (up to March 2000) was conducted to identify relevant English-language publications using paracetamol, children, infants and neonates as search terms. Additional studies were identified from bibliographies of the reviewed literature. Results: Pharmacological studies on paracetamol in infants are few. Most studies have focused on the administration of one single paracetamol dose, and the problem of cumulative toxicity with repeated dosing has not been addressed. Plasma paracetamol concentration should be 10?20 mg ml?1 to achieve antipyretic and analgesic effects. The bioavailability of the different formulations and routes of administration vary with age. Rectal absorption is slower and more erratic than the oral; however, in the very young, rectal bioavailability is higher than in older patients. Volume of distribution seems to be age-independent, whereas clearance is reduced in neonates and particularly in preterm babies. Neonates and infants are capable of forming the reactive intermediate metabolite that causes hepatocellular damage, particularly after multiple doses. They have an immature glucuronide conjugation system, but the rate constant for the sulphation metabolic pathway is larger than in older children, and this is the most important route of metabolism. Conclusions: The pharmacokinetics and pharmacodynamics of paracetamol differ substantially in neonates and infants from those in older children and adults; hence, dosing should be adjusted accordingly.
ER  - 

TY  - JOUR
AU  - Reeb, Jeremie
AU  - Cypel, Marcelo
TI  - Ex vivo lung perfusion
JO  - Clinical Transplantation
JA  - Clin Transplant
VL  - 30
IS  - 3
SN  - 0902-0063
UR  - https://doi.org/10.1111/ctr.12680
DO  - doi:10.1111/ctr.12680
SP  - 183
EP  - 194
KW  - donation after cardiac death
KW  - ex vivo lung perfusion
KW  - lung assessment/reconditioning/repair
KW  - lung transplantation
KW  - marginal donor lung
KW  - organ preservation
KW  - organ procurement
KW  - primary graft dysfunction
PY  - 2016
AB  - Abstract Lung transplantation is an established life-saving therapy for patients with end-stage lung disease. Unfortunately, greater success in lung transplantation is hindered by a shortage of lung donors and the relatively poor early-, mid-, and long-term outcomes associated with severe primary graft dysfunction. Ex vivo lung perfusion has emerged as a modern preservation technique that allows for a more accurate lung assessment and improvement in lung quality. This review outlines the: (i) rationale behind the method; (ii) techniques and protocols; (iii) Toronto ex vivo lung perfusion method; (iv) devices available; and (v) clinical experience worldwide. We also highlight the potential of ex vivo lung perfusion in leading a new era of lung preservation.
ER  - 

TY  - JOUR
TI  - Abstracts of the 9th Annual meeting of the Societe Francaise de Pharmacologie, 26th Pharmacovigilance meeting and 11th CHU CIC meeting (Bordeaux 26-28 April 2005)
JO  - Fundamental & Clinical Pharmacology
VL  - 19
IS  - 2
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2005.00328.x
DO  - doi:10.1111/j.1472-8206.2005.00328.x
SP  - 195
EP  - 253
PY  - 2005
ER  - 

TY  - JOUR
TI  - Scientific Programme, 43rd Annual Meeting of the International Continence Society (ICS) 26 – 30 August 2013, Barcelona, Spain
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodyn.
VL  - 32
IS  - 6
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.22472
DO  - doi:10.1002/nau.22472
SP  - 507
EP  - 932
PY  - 2013
ER  - 

TY  - JOUR
AU  - Whittaker, Kelly
AU  - Burgess, Rob
AU  - Jones, Valerie
AU  - Yang, Yanqing
AU  - Zhou, Weifan
AU  - Luo, Shuhong
AU  - Wilson, Jarad
AU  - Huang, Ruo-Pan
TI  - Quantitative proteomic analyses in blood: A window to human health and disease
JO  - Journal of Leukocyte Biology
JA  - J Leukoc Biol
VL  - 106
IS  - 3
SN  - 0741-5400
UR  - https://doi.org/10.1002/JLB.MR1118-440R
DO  - doi:10.1002/JLB.MR1118-440R
SP  - 759
EP  - 775
KW  - proteomics
KW  - cytokine
KW  - Parkinson's Disease
KW  - obesity
KW  - prostate cancer
KW  - breast cancer
KW  - colorectal cancer
KW  - lupus
KW  - IL-6
PY  - 2019
AB  - Abstract This review discusses how the measurement of proteins in blood and its components via quantitative proteomics analyses can inform health status. Various external and internal factors such as environmental conditions, genetic background, nutrition, diet, and lifestyle, chronic pathological conditions, disease state, or therapeutic intervention will be investigated and their effects on the protein profile will be shown. The resulting changes to ones? health and how this protein expression information can be used in early screening/diagnostic applications, drug discovery, precision treatment, patient management, and monitoring overall health status will also be presented.
ER  - 
